Cytomegalovirus (CMV) is generally described as a slowly replicating virus.
During studies of immunocompromised patients, we observed rapid changes in
the quantity of CMV DNA present in serial blood samples by quantitative-co
mpetitive polymerase chain reaction commensurate with a doubling time of <2
d. To further investigate the dynamics of replication in vivo, patients in
three distinct situations were studied in detail: (a) those receiving intr
avenous ganciclovir; (b) those in whom ganciclovir-resistant strains appear
ed during long-term therapy; and (c) those in whom ganciclovir-resistant st
rains disappeared with alternative drug therapy. In all cases, it was possi
ble to provide accurate estimates of the doubling time of CMV and its half-
life of disappearance after antiviral chemotherapy. The results from all th
ree approaches demonstrated that the doubling time/half-life of CMV in bloo
d is similar to 1 d when frequent samples are collected. These results show
that CMV DNA replication in vivo is a highly dynamic process. We conclude
that the reputation of CMV as a slowly replicating virus based on the time
taken to produce cytopathic effects in vitro is unwarranted. These findings
have implications for the potency, dose, and duration of antiviral chemoth
erapy needed for the effective treatment of this important human pathogen.